BridgeMD
Compares treatment options for Cervicogenic Headache
Official title Ischemic Compression Technique Versus Jones Technique in Cervicogenic Headache Patients
ClinicalTrials.gov ID: NCT06875869
What this study is testing
- What it's testing
- The primary objective of the study is to determine the effects of Jones and Ischemic compression technique on pain, range of motion and disability in patients with cervicogenic headache. Cervicogenic headache is a distinctive type of secondary headache where the pain originates from structures in the neck or cervical spine and radiates to the head.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 35
You may be able to join if
- Both males and females
- 25-35 years of age
- Individuals satisfying the Cervicogenic Headache criteria
- Positive Simon's criteria for trigger points
You likely can't join if
- primary headaches (i.e., migraine, tension type headache)
- bilateral headache
- Presence of any red flags
- cervical spinal stenosis
- evidence of central nervous system involvement
- prior surgery to the head or neck
The study team makes the final eligibility decision.
Where it's taking place
- Bahawalpur, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 35 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bahawalpur, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.